Skip to main content
Indian stocks: Visit www.stage2stocks.com →

MetLife, Inc.

Stage 2 · Advancing · week 20

As of Oct 22, 2026, MetLife is in Stage 2, the uptrend phase, now in week 20 (since Jun 3, 2026). It closed at $103.57, at its 52-week high and above its 200-day average, which is rising.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. More about the company

$103.57
+1.36% today
$65.8B · Large cap
Market Neutral — Fading

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 5 in Insurance - Life · #1 of 215 in Financials

Is MET early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 26w
S2 24w
S2 20w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 4w → S2 5w → S3 7w → S2 26w → S3 5w → S2 24w → S3 3w → S2 10w → S3 3w → S4 9w → S1 6w → S4 5w → S1 4w → S2 7w → S3 7w → S2 8w → S4 10w → S1 3w → S2 20w current
Total tracked: 165 weeks across 19 stage runs.

MET among Insurance - Life5th of 18 by relative strength

All 18 →
Stocks in Insurance - Life ranked by relative strength, with stage and one-month change
#StockStageRS1M
1ABXStage 4 · wk 286+8.8%
2MFCStage 2 · wk 2585+4.6%
3CNOStage 2 · wk 2583+2.7%
4JXNStage 2 · wk 1982+2.8%
5METStage 2 · wk 2079+6.6%
6GLStage 3 · wk 573−0.0%
7UNMStage 2 · wk 2573−0.8%
8PRUStage 3 · wk 271+0.5%
vs 52W High
0.0%
$66.77 lo$103.57 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 20
1w13w26w
Week 20, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
22.7%
200 DMA: $84.40 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.17x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+6.6%
3M
+9.9%
6M
+38.1%
YTD
+31.7%
1Y
+34.8%
Scan Membership
Breakout Watch
Latest: 2025-01-24
10 appearances in last 60 days. First seen: 2019-03-11.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 20 · Vol 1.17x
2026-10-21S2
Wk 20 · Vol 0.87x
2026-10-20S2
Wk 20 · Vol 0.70x
2026-10-19S2
Wk 20 · Vol 0.67x
2026-10-16S2
Wk 19 · Vol 1.10x
2026-10-15S2
Wk 19 · Vol 0.98x
2026-10-14S2
Wk 19 · Vol 1.18x
2026-10-13S2
Wk 19 · Vol 0.96x
2026-10-12S2
Wk 19 · Vol 0.73x
2026-10-09S2
Wk 18 · Vol 0.71x
2026-10-08S2
Wk 18 · Vol 0.91x
2026-10-07S2
Wk 18 · Vol 0.94x
Moving averages & range
50 DMA
$97.23
200 DMA
$84.40
52W High
$103.57
52W Low
$66.77
5D Low
$99.58
Resistance levels (recent highs)
20d High
$103.57
60d High
$103.57
120d High
$103.57
250d High
$103.57
Next resistance
Above all
P/E (TTM)
19.8
Forward 9.2
Earnings Growth (YoY)
+5.8%
Revenue +10.5%
ROE
+13.1%
Profit margin +4.6%
Dividend Yield
2.32%
P/B 2.4

MetLife: quick answers

What stage is MetLife in?

As of Oct 22, 2026, MetLife (MET) is in Stage 2, the uptrend phase. It entered Stage 2 on Jun 3, 2026 and is in week 20. What the four stages mean

Is MetLife in an uptrend?

Yes. MetLife is in a Stage 2 uptrend. It trades 22.7% above its 200-day average, which is rising.

How far is MetLife from its 52-week high?

MetLife closed at $103.57 on Oct 22, 2026, at its 52-week high. Its 52-week low is $66.77.

How has MetLife performed over the past year?

As of Oct 22, 2026, MetLife is up 34.8% over the past year and up 31.7% so far in 2026.

Which sector and industry is MetLife in?

MetLife is in the Insurance - Life industry, part of the Financials sector.

About this companyFinancials· Insurance - Life

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.